News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
December 21, 2020
2020

AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico

Read article
News
December 16, 2020
2020

AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares

Read article
News
December 11, 2020
2020

AbCellera Announces Pricing of Initial Public Offering

Read article
News
November 20, 2020
2020

AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19

Read article
News
November 19, 2020
2020

Peter Thiel Joins AbCellera's Board of Directors

Read article
News
November 19, 2020
2020

AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health

Read article
News
November 18, 2020
2020

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

Read article
News
November 18, 2020
2020

John Montalbano Joins AbCellera's Board of Directors

Read article
Event
November 17, 2020
2020

Antibody Engineering and Therapeutics US 2020

Read article
News
November 10, 2020
2020

AbCellera-Discovered Antibody Receives U.S. FDA Emergency Use Authorization as a Monotherapy for the Treatment of COVID-19

Read article